| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A mechanism-based binding model for the population pharmacokinetics and pharmacodynamics of omalizumab
|
Hayashi, Naoto
|
|
2007
|
63 |
5 |
p. 548-561
|
article
|
| 2 |
Assessment of renal function in clinical practice at the bedside of burn patients
|
Conil, J. M.
|
|
2007
|
63 |
5 |
p. 583-594
|
article
|
| 3 |
Authors' response: Poor correlation between 6β-hydroxycortisol:cortisol molar ratios and midazolam clearance as measure of hepatic CYP3A activity: a comment
|
Chen, Ya-Chi
|
|
2007
|
63 |
5 |
p. 633
|
article
|
| 4 |
Bayesian modelling and ROC analysis to predict placebo responders using clinical score measured in the initial weeks of treatment in depression trials
|
Gomeni, Roberto
|
|
2007
|
63 |
5 |
p. 595-613
|
article
|
| 5 |
Drug therapy in kidney disease
|
Aronson, Jeffrey K
|
|
2007
|
63 |
5 |
p. 509-511
|
article
|
| 6 |
Effects of gastric emptying on oral mycophenolic acid pharmacokinetics in stable renal allograft recipients
|
Naesens, Maarten
|
|
2007
|
63 |
5 |
p. 541-547
|
article
|
| 7 |
Erratum
|
|
|
2007
|
63 |
5 |
p. 635
|
article
|
| 8 |
Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers
|
van Doorn, Martijn
|
|
2007
|
63 |
5 |
p. 562-574
|
article
|
| 9 |
Palatability of angiotensin II antagonists among nephropathic children
|
Meier, Chiara M.
|
|
2007
|
63 |
5 |
p. 628-631
|
article
|
| 10 |
Pharmacokinetics and safety assessments of high-dose and 4-week treatment with S-3304, a novel matrix metalloproteinase inhibitor, in healthy volunteers
|
Mant, Timothy G. K.
|
|
2007
|
63 |
5 |
p. 512-526
|
article
|
| 11 |
Pharmacokinetics of a novel agent, R667, in patients with emphysema
|
Chiu, Yu-Yuan
|
|
2007
|
63 |
5 |
p. 527-533
|
article
|
| 12 |
Pharmacokinetics of desloratadine in children between 2 and 11 years of age
|
Gupta, Samir
|
|
2007
|
63 |
5 |
p. 534-540
|
article
|
| 13 |
Poor correlation between 6β-hydroxycortisol:cortisol molar ratios and midazolam clearance as measure of hepatic CYP3A activity: a comment
|
Fenske, Martin
|
|
2007
|
63 |
5 |
p. 632
|
article
|
| 14 |
Quality of requests for serum digoxin concentrations: experience from an Australian Regional Health Service
|
Ellington, Chris
|
|
2007
|
63 |
5 |
p. 623-627
|
article
|
| 15 |
Reverse transcriptase inhibitors in HIV/AIDS therapy
|
|
|
2007
|
63 |
5 |
p. 634
|
article
|
| 16 |
Single-dose pharmacokinetics of levetiracetam in healthy Chinese male subjects
|
Zhao, Qian
|
|
2007
|
63 |
5 |
p. 614-617
|
article
|
| 17 |
The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertension
|
Lefebvre, Jean
|
|
2007
|
63 |
5 |
p. 575-582
|
article
|
| 18 |
Unexpected relationship between plasma protein binding and the pharmacodynamics of 2-NAP, a CCK1-receptor antagonist
|
Gerskowitch, V. P.
|
|
2007
|
63 |
5 |
p. 618-622
|
article
|
Journal description